The past decade has seen rapid growth of research into the prevention and early detection of ovarian cancer. Screening studies have been met with mixed results and the newly identified putative precursor lesions within the distal fallopian tube have become well accepted. This conference is an outreach of the Department of Defense-sponsored ovarian cancer research consortium on early molecular changes associated with disease. This symposium will bring together leading researchers to discuss progress made toward prevention and early detection of ovarian cancer. Only through understanding the origins of ovarian cancer is progress likely to be made in these important areas.
Upon conclusion of this program, participants should be able to:
Understand the current molecular approaches to prevention and early detection of ovarian cancer
Obtain an update on the latest molecular findings implicating the distal fallopian tube as the site of origin for most ovarian cancer
Learn how current laboratory research will impact future prevention and treatment
As part of the 4th Annual Ovarian Cancer Symposium, which will take place on May 13 and 14, 2013, it is our pleasure to invite you to submit an abstract for poster presentation. Abstracts for presentation will be selected on merit, with priority given to early detection and prevention, in accordance with the symposium theme; however, abstracts related to any area of ovarian cancer research will be considered. Abstract submission is open to individuals of all professional and academic levels involved in ovarian cancer research. Travel expenses are the responsibility of the individual, but registration fees will be waived for poster presenters.
Abstracts should be submitted as a double-spaced, single-page (or less) word document in standard abstract format, accompanied by the contact information of the presenter. Please submit your abstract by Email to: email@example.com no later than May 1, 2013. Presenters of accepted abstracts will be notified on May 3, 2013. Poster boards are 5’ x 6’.
This course consists of didactic lectures with question and discussion periods.
This activity is designed for gynecologists, gynecologic oncologists and other physicians and other healthcare professionals.
Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.